• In recent days, Intuitive Surgical disclosed that a targeted phishing-related cybersecurity breach gave an unauthorized third party access to certain internal IT business applications, exposing limited customer and employee data but leaving its da Vinci and Ion robotic platforms fully operational.

• This incident highlights how cybersecurity and data-protection practices are becoming as important to hospitals and investors as surgical performance when evaluating robotic-surgery partners.

• We’ll now examine how this cybersecurity breach, despite leaving core surgical systems unaffected, could influence Intuitive Surgical’s broader investment narrative.

Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 29 best rare earth metal stocks of the very few that mine this essential strategic resource.

To own Intuitive Surgical, you need to believe robotic-assisted surgery remains central to how hospitals deliver minimally invasive care, supported by growing procedures and high recurring revenue from instruments and services. The main near term catalyst is continued adoption of the da Vinci 5 platform and its new indications, while the biggest current risk is the company’s premium valuation, which leaves little room for operational or regulatory missteps. The recent phishing-related cybersecurity breach does not appear to materially change that picture so far.

Against that backdrop, the recent FDA clearance for several cardiac procedures on the da Vinci 5 system is particularly important. It opens a new specialty for Intuitive that could expand the platform’s addressable market and deepen its role inside hospitals, reinforcing procedure growth as a core catalyst. How quickly cardiac centers actually adopt robotic approaches, especially while hospitals weigh cybersecurity practices and high capital costs, will be a key area to watch for shareholders.

Yet while growth looks attractive, investors should also be aware that…

Read the full narrative on Intuitive Surgical (it’s free!)

Intuitive Surgical’s narrative projects $13.4 billion revenue and $3.7 billion earnings by 2028. This requires 13.5% yearly revenue growth and about a $1.1 billion earnings increase from $2.6 billion today.

Uncover how Intuitive Surgical’s forecasts yield a $611.82 fair value, a 30% upside to its current price.

Some of the most optimistic analysts were projecting revenue of about US$14.6 billion and earnings of roughly US$4.1 billion by 2028, which assumes faster adoption and stronger margins than consensus. Compared with baseline expectations, that is a much more aggressive story, especially if regulatory setbacks in markets like Europe and Japan or new cyber and compliance requirements start to slow product rollout. As a shareholder, it is worth asking whether those higher forecasts still feel realistic now that this breach has reminded everyone how quickly risk can…